whitepaper

Application note: Improving High Throughput AlphaLISA® with The TEMPEST®

Posted: 14 August 2020 | | No comments yet

Using TEMPEST®, St. Jude Children’s Research Hospital were able to rapidly screen a focused compound library for early cancer drug candidates in an AlphaLISA® assay.

Using the TEMPEST® liquid handler from Formulatrix, and in collaboration with HighRes Biosolutions® for integration of the instrument with an existing automation platform, researchers at St. Jude Children’s Research Hospital were able to rapidly screen a focused compound library screening early cancer drug candidates in an AlphaLISA® assay. The success of this project was facilitated by a number of key TEMPEST® features, namely an in-built capacity to recirculate the AlphaLISA® beads, the ability to dispense multiple reagents from a single dispenser, and extremely low dead volumes.











    To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *

    *

    *

    *

    This content is provided to you for free thanks to the kind support of our sponsor: Formulatrix

    Send this to a friend